Ban Zhi Lian

Star

Scutellaria barbata D. Don

Genus: Scutellaria Species: barbata Pinyin: Ban Zhi Lian
Barbat Skullcap Herb半枝莲

☯ TCM Properties

Category: clearing heat
Temperature: cold
Taste: pungent, bitter
Meridians: lung, liver, kidney
Functions:

Clears Heat and Resolves Toxicity; Resolves Fire toxins (especially tumors and sores); Invigorates Blood and Dispels Stasis; Stops Bleeding; Promotes Urination and Reduces Edema; Reduces Swelling and Alleviates Pain

Traditional Chinese Uses

Ban Zhi Lian (scutellaria barbata herb) is a cold, bitter herb with a strong reputation in Chinese medicine for clearing Heat toxin, reducing swelling, and dispersing Blood stasis. It is used for toxic swellings, snake bites, carbuncles, and inflammatory conditions involving Heat toxin and Blood stasis. Modern Chinese medicine has employed it extensively in oncology-adjacent formulas, often combined with Bai Hua She She Cao, for conditions where Heat toxin and stasis are prominent features.

Botanical Description

Scutellaria barbata, barbed skullcap, is a slender erect perennial herb of the family Lamiaceae native to moist grasslands, paddy margins and streamsides throughout central, southern and eastern China, Korea, Japan and parts of Southeast Asia. It produces a short, fibrous-rooted rhizome and quadrangular, sparsely pubescent stems 15-55 cm tall, branched from the base. The opposite, short-petiolate, triangular-ovate to lanceolate leaves are 1.5-3 cm long with shallowly crenate margins and a truncate to broadly cuneate base. Small bilabiate flowers 1-1.5 cm long are borne singly in the upper leaf axils, arranged in unilateral leafy racemes; the corolla is bluish-purple with the characteristic Scutellaria-typical scutellum (shield-like outgrowth) on the upper calyx lip, which enlarges and persists in fruit. The four small ovoid nutlets mature within the closed lower calyx lip. The whole flowering herb with root is harvested in summer.

Active Constituents

Scutellarin

Flavone glycoside

Concentration: One of the principal flavonoids; a validated marker in Chinese Pharmacopoeia assays

A flavone glucuronide with antioxidant, anti-inflammatory and antiproliferative activity. In tumor models it contributes to inhibition of cell proliferation and induction of apoptosis, and is used as a quality-control marker for the herb.

Scutellarein

Flavone (aglycone)

Concentration: Minor to moderate aglycone constituent

The aglycone of scutellarin; shows antioxidant and anti-tumor activity and inhibits several inflammatory mediators.

Luteolin

Flavone

Concentration: Documented flavonoid constituent

Broadly studied flavone that induces apoptosis and cell-cycle arrest and downregulates matrix metalloproteinases (MMP-2/MMP-9), reducing tumor-cell invasion and migration.

Apigenin

Flavone

Concentration: Present as free aglycone and glycosides (e.g., apigenin-5-O-glucoside)

Pro-apoptotic and anti-angiogenic flavone; modulates PI3K/Akt/mTOR, MAPK and NF-κB signalling in cancer-cell models.

Wogonin

Flavone

Concentration: Documented flavonoid constituent

O-methylated flavone with anti-inflammatory and anticancer activity, promoting apoptosis and suppressing NF-κB-driven proliferation.

Baicalein

Flavone

Concentration: Documented flavonoid constituent

Antioxidant flavone reported to inhibit tumor-cell growth and angiogenesis and to modulate immune cytokine profiles.

Scutebarbatines (e.g., scutebarbatine C, D, E)

neo-Clerodane diterpenoid alkaloids

Concentration: Characteristic diterpenoid class; multiple congeners isolated

Diterpenoid alkaloids nearly unique to S. barbata; several show cytotoxicity against tumor cell lines and reversal of multidrug resistance in vitro.

Quercetin

Flavonol

Concentration: Minor flavonol constituent

Antioxidant flavonol contributing to free-radical scavenging and pro-apoptotic signalling.

⚠ Drug Interactions

Hepatotoxic drugs (e.g., high-dose acetaminophen, methotrexate)

Moderate Evidence: Theoretical

Concentrated S. barbata aqueous extract (BZL101) produced reversible transaminase elevation, including a grade 4 AST rise, in a phase 1B trial. Co-use with other hepatotoxic agents could theoretically compound liver enzyme elevation.

Clinical note: Monitor liver function if used in high doses alongside hepatotoxic medications.

Cytochrome P450 / P-gp substrate drugs

Minor Evidence: Theoretical

Flavonoids such as luteolin, apigenin, wogonin and baicalein can inhibit selected CYP isoenzymes and efflux transporters in vitro, which could theoretically alter plasma concentrations of co-administered substrate drugs.

Clinical note: Clinical significance in humans is unconfirmed; use caution with narrow-therapeutic-index drugs.

Dosage

FormAmount Frequency Duration Population Notes
decoction 6-15g Daily

Preparation Methods

Decoction (water extract)

Parts: whole herb (aerial parts)

Typically 15-30 g of the dried whole herb (larger doses used in oncological support) is decocted in water. In classical practice it is combined with other heat-clearing, toxicity-resolving and blood-invigorating herbs.

Fresh herb / external application

Parts: fresh whole herb

Fresh herb may be crushed and applied topically to sores, swellings and snakebite in traditional use, or the juice expressed and taken.

Clinical Studies

Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer

Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z, Tripathy D (2007) Breast Cancer Research and Treatment Phase 1A clinical trial (open-label)

An orally administered aqueous extract of S. barbata (BZL101) was evaluated in heavily pretreated metastatic breast cancer patients. It was well tolerated with predominantly low-grade gastrointestinal toxicity and showed early signals of disease stabilization.

A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer

Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL (2010) Breast Cancer Research and Treatment Phase 1B dose-escalation clinical trial (multicenter)

Twenty-seven women with metastatic breast cancer received escalating doses of BZL101 up to 40 g/day. Grade 3-4 adverse events were uncommon; the maximum tolerated dose was not reached, and 21% of patients had stable disease for more than 120 days.

Historical Texts

Ben Cao Gang Mu Shi Yi (Supplement to the Compendium of Materia Medica), Zhao Xuemin

Qing dynasty (1765)
Records Ban Zhi Lian among heat-clearing, toxicity-resolving herbs used for swellings, sores and snakebite.

Guangxi / Fujian folk materia medica traditions

Traditional (documented in modern provincial herbals)
Long-standing southern Chinese folk use for abscesses, hepatitis and tumors, later systematized in modern TCM oncology practice.

References

  1. Wang Y, et al.. Chemical Constituents, Anti-Tumor Mechanisms, and Clinical Application: A Comprehensive Review on Scutellaria barbata . Molecules (2024) [DOI]
  2. Gao J, Yin W, Corcoran O. From Scutellaria barbata to BZL101 in Cancer Patients: Phytochemistry, Pharmacology, and Clinical Evidence . Natural Product Communications (2019) [DOI]
  3. Chen VP, et al.. Scutellaria barbata: A Review on Chemical Constituents, Pharmacological Activities and Clinical Applications . Current Medicinal Chemistry (2020) [DOI]

This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.

📝 Notes

Public notes from the community and your own private notes on Ban Zhi Lian.

No notes yet.

Log in or register to add your own notes.

Back to Herb Database